$71.52
0[0.00%]
At close: Apr 25
$71.52
0[0.00%]
PreMarket: 4:20PM EDT
Axsome Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Axsome Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | AXSM | Q1 | -$0.26 | -$1.19 | — | — | $94.58M | $74.63M | — | — | Get Alert |
02/20/2024 | AM | AXSM | Q4 | -$1.41 | -$1.15 | -$0.73 | 36.52% | $24.37M | $67.69M | $71.53M | 5.67% | Get Alert |
11/06/2023 | AM | AXSM | Q3 | -$1.07 | -$1.19 | -$1.32 | -10.92% | $16.85M | $55.75M | $57.79M | 3.67% | Get Alert |
08/07/2023 | AM | AXSM | Q2 | -$1.06 | -$1.24 | -$1.54 | -24.19% | $8.82M | $40.19M | $46.70M | 16.20% | Get Alert |
05/08/2023 | AM | AXSM | Q1 | -$1.03 | -$1.04 | -$0.26 | 75.00% | $0.00 | $26.07M | $94.58M | 262.78% | Get Alert |
02/27/2023 | AM | AXSM | Q4 | -$0.90 | -$1.14 | -$1.41 | -23.68% | $0.00 | $21.76M | $24.37M | 12.00% | Get Alert |
11/07/2022 | AM | AXSM | Q3 | -$0.93 | -$1.08 | -$1.07 | 0.93% | $0.00 | $17.53M | $16.85M | -3.90% | Get Alert |
08/09/2022 | AM | AXSM | Q2 | -$0.86 | -$1.24 | -$1.06 | 14.52% | $0.00 | $6.29M | $8.82M | 40.22% | Get Alert |
05/02/2022 | AM | AXSM | Q1 | -$0.78 | -$1.00 | -$1.03 | -3.00% | $0.00 | — | $0.00 | — | Get Alert |
03/01/2022 | AM | AXSM | Q4 | -$0.78 | -$1.03 | -$0.90 | 12.62% | $0.00 | — | $0.00 | — | Get Alert |
11/08/2021 | AM | AXSM | Q3 | -$0.61 | -$0.95 | -$0.93 | 2.11% | $0.00 | — | $0.00 | — | Get Alert |
08/09/2021 | AM | AXSM | Q2 | -$0.49 | -$0.97 | -$0.86 | 11.34% | $0.00 | — | $0.00 | — | Get Alert |
05/10/2021 | AM | AXSM | Q1 | -$0.88 | -$0.87 | -$0.78 | 10.34% | $0.00 | — | $0.00 | — | Get Alert |
03/01/2021 | AM | AXSM | Q4 | -$0.71 | -$0.76 | -$0.78 | -2.63% | $0.00 | — | $0.00 | — | Get Alert |
11/05/2020 | AM | AXSM | Q3 | -$0.56 | -$0.57 | -$0.61 | -7.02% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2020 | AM | AXSM | Q2 | -$0.41 | -$0.62 | -$0.49 | 20.97% | $0.00 | — | $0.00 | — | Get Alert |
05/08/2020 | AM | AXSM | Q1 | -$0.32 | -$0.62 | -$0.88 | -41.94% | $0.00 | — | $0.00 | — | Get Alert |
03/12/2020 | AM | AXSM | Q4 | -$0.32 | -$0.48 | -$0.71 | -47.92% | $0.00 | — | $0.00 | — | Get Alert |
11/07/2019 | AM | AXSM | Q3 | -$0.31 | -$0.40 | -$0.56 | -40.00% | $0.00 | — | $0.00 | — | Get Alert |
Axsome Therapeutics (AXSM) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 20, 2024 for Q4.
The Actual EPS was $-0.73, which beat the estimate of $-1.15.
The Actual Revenue was $71.5M, which beat the estimate of $67.7M.
Browse earnings estimates, EPS, and revenue on all stocks.